Related Experiment Video
Updated: Feb 17, 2026

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
Reduced Transferrin Levels in Active Inflammatory Bowel Disease
Malgorzata Matusiewicz1, Katarzyna Neubauer2, Paulina Lewandowska1
1Department of Medical Biochemistry, Wroclaw Medical University, Chalubinskiego 10, 50-368 Wroclaw, Poland.
Transferrin levels reflect overall patient condition in inflammatory bowel disease (IBD), correlating with inflammation, malnutrition, and oxidative stress. This marker shows promise for assessing disease activity in Crohn's disease and ulcerative colitis.
Area of Science:
- Gastroenterology
- Biochemistry
- Immunology
Background:
- Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), presents diagnostic challenges and is often complicated by anemia and malnutrition.
- C-reactive protein (CRP) is currently the sole biochemical marker with clinical significance in IBD management.
- The complex interplay of inflammation, malnutrition, anemia, and oxidative stress in IBD necessitates a comprehensive marker for patient assessment.
Purpose of the Study:
- To investigate whether transferrin, influenced by multiple disease factors, serves as a superior indicator of the overall condition in IBD patients compared to specific indices.
- To evaluate the correlation of transferrin levels with markers of inflammation, anemia, malnutrition, and oxidative stress in CD and UC patients.
Main Methods:
- A cohort of 137 IBD patients (63 CD, 74 UC) and 97 controls were analyzed.
- Measurements included transferrin, CRP, erythrocyte sedimentation rate (ESR), leukocytes, platelets, various cytokines (IL-6, IL-10, TNF-α, IL-1), albumin, cholesterol, hemoglobin, hematocrit, erythrocytes, iron, and oxidative stress markers (paraoxonase-1, catalase, glutathione peroxidase-1, superoxide dismutase-1).
Main Results:
- Transferrin levels were reduced in active CD and UC, showing significant negative correlations with disease activity scores (CD: ρ = -0.49; UC: ρ = -0.52).
- In UC, transferrin correlated negatively with inflammatory markers (CRP, ESR, leukocytes, platelets, IL-6, IL-10, TNF-α) and positively with nutritional and anemia markers (albumin, cholesterol, hemoglobin, hematocrit, erythrocytes, iron).
- In CD, transferrin correlated negatively with inflammatory markers (CRP, leukocytes, platelets, IL-1, IL-6) and positively with nutritional and oxidative stress markers (albumin, iron, catalase, GPx-1, SOD-1, paraoxonase-1).
- Associations with inflammation and anemia/malnutrition were stronger in UC, while associations with oxidative stress were more pronounced in CD.
- Transferrin demonstrated superior performance as a UC activity marker compared to ESR and hemoglobin.
Conclusions:
- Transferrin serves as a valuable indicator reflecting the global condition of IBD patients, integrating aspects of inflammation, malnutrition, and oxidative stress.
- Transferrin's robust correlations with disease activity and various biochemical markers suggest its potential as a comprehensive assessment tool in IBD.
- Transferrin may offer a more sensitive marker for monitoring disease activity in ulcerative colitis than currently used indices like ESR and hemoglobin.
More Related Videos
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...